Clinical trial
Autologous or Donor Stem Cell Transplantation in Treating Patients With…
NCT00096460 · Medical College of Wisconsin, Other · Terminated
Key facts
| NCT number | NCT00096460 |
|---|---|
| Title | Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) |
| Official title | Autologous Versus Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Patients With Chemosensitive Follicular Non-Hodgkin's Lymphoma Beyond First Complete Response or First Partial Response (BMT CTN #0202) |
| Lead sponsor | Medical College of Wisconsin, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH Blood and Marrow Transplant Clinical Trials Network National Cancer Institute (NCI) National Marrow Donor Program |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Follicular Lymphoma |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | Cyclophosphamide and Rituximab, Filgrastim, Chemotherapy or Radiation therapy, Non-myeloablative Conditioning regimen, Allogeneic transplant, Autologous transplant, Rituximab maintenance therapy, GVHD Prophylaxis |
| Enrollment | 30 |
| Start date | Aug 1, 2004 |
| Primary completion | Mar 1, 2006 |
| Completion | Mar 1, 2009 |
| First posted | Nov 10, 2004 |
| Last update posted | Jan 5, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: